Paragon Capital Management LLC Takes $146,000 Position in Thermo Fisher Scientific Inc. (TMO)

Paragon Capital Management LLC purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 533 shares of the medical research company’s stock, valued at approximately $146,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Ropes Wealth Advisors LLC increased its stake in Thermo Fisher Scientific by 51.4% during the 1st quarter. Ropes Wealth Advisors LLC now owns 330 shares of the medical research company’s stock worth $90,000 after acquiring an additional 112 shares during the period. Retirement Systems of Alabama increased its stake in shares of Thermo Fisher Scientific by 0.4% in the 1st quarter. Retirement Systems of Alabama now owns 420,856 shares of the medical research company’s stock valued at $115,197,000 after purchasing an additional 1,704 shares during the last quarter. CMH Wealth Management LLC bought a new position in shares of Thermo Fisher Scientific in the 1st quarter valued at $241,000. Louisiana State Employees Retirement System increased its stake in shares of Thermo Fisher Scientific by 0.9% in the 1st quarter. Louisiana State Employees Retirement System now owns 21,300 shares of the medical research company’s stock valued at $5,830,000 after purchasing an additional 200 shares during the last quarter. Finally, Portland Global Advisors LLC acquired a new stake in shares of Thermo Fisher Scientific during the 1st quarter valued at $217,000. 88.66% of the stock is owned by hedge funds and other institutional investors.

Several equities research analysts recently weighed in on TMO shares. Bank of America reissued a “buy” rating and set a $300.00 price objective (up previously from $285.00) on shares of Thermo Fisher Scientific in a report on Tuesday. BTIG Research raised their price objective on Thermo Fisher Scientific to $290.00 and gave the company a “buy” rating in a report on Thursday, January 31st. Barclays raised their price objective on Thermo Fisher Scientific from $275.00 to $280.00 and gave the company an “overweight” rating in a report on Thursday, January 3rd. UBS Group raised their price objective on Thermo Fisher Scientific to $305.00 and gave the company a “buy” rating in a report on Monday, March 25th. Finally, Needham & Company LLC initiated coverage on Thermo Fisher Scientific in a report on Wednesday, January 2nd. They set a “strong-buy” rating and a $271.00 price objective on the stock. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $289.92.

In other Thermo Fisher Scientific news, SVP Gregory J. Herrema sold 5,400 shares of the stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $251.51, for a total transaction of $1,358,154.00. Following the sale, the senior vice president now owns 31,846 shares in the company, valued at $8,009,587.46. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Peter E. Hornstra sold 5,920 shares of the stock in a transaction on Friday, February 15th. The stock was sold at an average price of $250.00, for a total value of $1,480,000.00. Following the sale, the chief accounting officer now owns 17,057 shares in the company, valued at approximately $4,264,250. The disclosure for this sale can be found here. In the last quarter, insiders sold 36,927 shares of company stock worth $9,388,124. 0.49% of the stock is owned by company insiders.

Shares of Thermo Fisher Scientific stock opened at $266.83 on Wednesday. Thermo Fisher Scientific Inc. has a one year low of $202.83 and a one year high of $282.98. The stock has a market capitalization of $110.75 billion, a P/E ratio of 24.00, a PEG ratio of 1.83 and a beta of 1.13. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.73 and a quick ratio of 1.24.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, January 30th. The medical research company reported $3.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.19 by $0.06. The company had revenue of $6.51 billion during the quarter, compared to analyst estimates of $6.26 billion. Thermo Fisher Scientific had a return on equity of 16.86% and a net margin of 12.06%. Thermo Fisher Scientific’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the company posted $2.79 earnings per share. Analysts expect that Thermo Fisher Scientific Inc. will post 12.15 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 16th. Investors of record on Friday, March 15th were paid a $0.19 dividend. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $0.76 annualized dividend and a yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio is presently 6.83%.

ILLEGAL ACTIVITY NOTICE: “Paragon Capital Management LLC Takes $146,000 Position in Thermo Fisher Scientific Inc. (TMO)” was published by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/04/17/paragon-capital-management-llc-takes-146000-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Further Reading: Treasury Bonds

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.